Login / Signup

Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials.

Rocio SedanoMalcolm HoganCassandra McDonaldTina Aswani-OmprakashChristopher MaVipul Jairath
Published in: Inflammatory bowel diseases (2022)
Keyphrases
  • ulcerative colitis
  • clinical trial
  • adverse drug
  • phase ii
  • open label
  • double blind
  • phase iii
  • emergency department